Alcohol extracts of Echinacea inhibit production of nitric oxide and tumor necrosis factor-alpha by macrophages in vitro

Food and Agricultural Immunology

Volumn 18, Issue 3-4, 2007, Pages 221-236

  Zhai, Zili ^a   Haney, Devon ^a   Wu, Lankun ^a   Solco, Avery ^a   Murphy, Patricia A ^a   Wurtele, Eve S ^a   Kohut, Marian L ^a   Cunnick, Joan E ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Echinacea; Macrophage; Nitric oxide; Phagocytosis; Tumor necrosis factor alpha

Indexed keywords

BACTERIA (MICROORGANISMS); ECHINACEA ANGUSTIFOLIA; ECHINACEA PALLIDA; ECHINACEA PURPUREA; MURINAE; SALMONELLA ENTERICA;

EID: 36749001645     PISSN: 09540105     EISSN: 14653443     Source Type: Journal    
DOI: 10.1080/09540100701797363     Document Type: Article

References (35)

1. Alam MS, Akaike T, Okamoto S, Kubota T, Yoshitake J, Sawa T, Miyamoto Y, Tamura F, Maeda H. 2002. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immunol 70:3130-3142.
2. Babu US, Gaines DW, Lillehoj H, Raybourne RB. 2006. Differential reactive oxygen and nitrogen production and clearance of Salmonella serovars by chicken and mouse macrophages. Dev Comp Immunol 30:942-953.
3. Baeuerle PA, Baltimore D. 1996. NF-kappa B: ten years after. Cell 87:13-20.
4. Barnes J, Anderson LA, Gibbons S, Phillipson JD. 2005. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 57:929-954.
5. Bodinet C, Lindequist U, Teuscher E, Freudenstein J. 2002. Effect of an orally applied herbal immunomodulator on cytokine induction and antibody response in normal and immunosuppressed mice. Phytomedicine 9:606-613.
6. Brune B, Gotz C, Messmer UK, Sandau K, Hirvonen MR, Lapetina EG. 1997. Superoxide formation and macrophage resistance to nitric oxide-mediated apoptosis. J Biol Chem 272:7253-7258.
7. Burger RA, Torres AR, Warren RP, Caldwell VD, Hughes BG. 1997. Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol 19:371-379.
8. Burgner D, Rockett K, Kwiatkowski D. 1999. Nitric oxide and infectious diseases. Arch Dis Child 81:185-188.
9. Chang CY, Tucci M, Baker RC. 2000. Lipopolysaccharide-stimulated nitric oxide production and inhibition of cell proliferation is antagonized by ethanol in a clonal macrophage cell line. Alcohol 20:37-43.
10. Chen Y, Fu T, Tao T, Yang J, Chang Y, Wang M, Kim L, Qu L, Cassady J, Scalzo R, Wang X. 2005. Macrophage activating effects of new alkamides from the roots of Echinacea species. J Nat Prod 68:773-776.
11. Cherayil BJ, Antos D. 2001. Inducible nitric oxide synthase and Salmonella infection. Microbes Infect 3:771-776.
12. Chou SH, Kojic LD, Cunnick JE. 1997. Evidence for the involvement of catecholamines in the 2-DG-induced immunomodulatory effects in spleen. Brain Behav Immunol 11:79-93.
13. Currier NL, Miller SC. 2000. Natural killer cells from aging mice treated with extracts from Echinacea purpurea are quantitatively and functionally rejuvenated. Exp Gerontol 35:627-639.
14. Dalby-Brown L, Barsett H, Landbo AK, Meyer AS, Molgaard P. 2005. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteins. J Agric Food Chem 53:9413-9423.
15. Facino RM, Carini M, Aldini G, Saibene L, Pietta P, Mauri P. 1995. Echinacoside and caffeoyl conjugates protect collagen from free radical-induced degradation: a potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 61:510-514.
16. Fortier AH, Falk LA. 1994. Isolation of murine macrophages. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strobber W, editors. Current protocols in immunology. New York: John Wiley and Sons, Inc. p 14.1.1-14.1.9.
17. Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, Basu TK. 2002. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol 2:381-387.
18. Hu C, Kitts DD. 2000. Studies on the antioxidant activity of Echinacea root extract. J Agric Food Chem 48:1466-1472.
19. MacMicking J, Xie QW, Nathan C. 1997. Nitric oxide and macrophage function. Annu Rev Immunol15:323-350.
20. Nussler AK, Billiar TR. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 54:171-178.
21. Park JE, Barbul A. 2004. Understanding the role of immune regulation in wound healing. Am J Surg 187:11S-16S.
22. Pellati F, Benvenuti S, Magro L, Melegari M, Soragni F. 2004. Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. J Pharm Biomed Anal 35:289-301.
23. Percival SS. 2000. Use of Echinacea in medicine. Biochem Pharmacol 60:155-158.
24. Pruett SB, Fan R, Zheng Q, Schwab C. 2005. Differences in IL-10 and IL-12 production patterns and differences in the effects of acute ethanol treatment on macrophages in vivo and in vitro. Alcohol 37:1-8.
25. Raso GM, Pacilio M, Di Carlo G, Esposito E, Pinto L, Meli R. 2002. In-vivo and in-vitro anti-inflammatory effect of Echinacea purpurea and Hypericum perforatum. J Pharm Pharmacol 54:1379-1383.
26. Salmon-Her V, Ramont L, Godeau G, Birembaut P, Guenounou M, Bernard P, Maquart FX. 2000. Implication of interleukin-4 in wound healing. Lab Invest 80:1337-1343.
27. Sato Y, Ohshima T, Kondo T. 1999. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 265:194-199.
28. Sharma M, Arnason JT, Hudson JB. 2006. Echinacea extracts modulate the production of multiple transcription factors in uninfected cells and rhinovirus-infected cells. Phytother Res 20:1074-1079.
29. Speroni E, Govoni P, Guizzardi S, Renzulli C, Guerra MC. 2002. Anti-inflammatory and cicatrizing activity of Echinacea pallida Nutt. root extract. J Ethnopharmacol 79:265-272.
30. Steinmuller C, Roesler J, Grottrup E, Franke G, Wagner H, Lohmann-Matthes ML. 1993. Polysaccharides isolated from plant cell cultures of Echinacea purpurea enhance the resistance of immunosuppressed mice against systemic infections with Candida albicans and Listeria monocytogenes. Int J Immunopharmacol 15:605-614.
31. Stimpel M, Proksch A, Wagner H, Lohmann-Matthes ML. 1984. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infect Immunol 46:845-849.
32. Tubaro A, Tragni E, Del Negro P, Galli CL, Della Loggia R. 1987. Anti-inflammatory activity of a polysaccharidic fraction of Echinacea angustifolia. J Pharm Pharmacol 39:567-569.
33. Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C, Kleinhappl B, Bauer R. 2006. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system. Int J Clin Pharmacol Ther 44:401-408.
34. Wu L, Bae J, Kraus G, Wurtele ES. 2004. Diacetylenic isobutylamides of Echinacea: synthesis and natural distribution. Phytochemistry 65:2477-2484.
35. Zhai Z, Liu Y, Wu L, Senchina DS, Wurtele ES, Murphy PA, Kohut ML, Cunnick JE. 2007. Enhancement of innate and adaptive immune functions by multiple Echinacea species. J Med Food 10:423-434.